Lexeo Therapeutics, Inc. (LXEO) Tops Q4 EPS by 59c

Lexeo Therapeutics, Inc. (NASDAQ: LXEO) reported Q4 EPS of ($0.27), $0.59 better than the analyst estimate of ($0.86).

For earnings history and earnings-related data on Lexeo Therapeutics, Inc. (LXEO) click here.

You May Also Be Interested In

• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
• Blue Moon Metals cleared to build at Nevada tungsten project
• Deere shares climb as fiscal Q3 earnings and revenue top estimates